Literature DB >> 19348711

Management of brain metastases.

John H Suh1, Samuel T Chao, Michael A Vogelbaum.   

Abstract

Brain metastases represent a common and devastating complication of cancer. With advances in surgery, radiology, and medical and radiation oncology, the number of treatment options have greatly increased. In addition, the prognosis for patients can vary widely depending on factors such as the number of lesions, extent of extracranial disease, age, and functional status. Recently, the possible impairment of whole brain radiation therapy on neurocognitive function has been a subject of concern and debate. Thus, the use of whole brain radiation therapy in conjunction with other treatment modalities should be optimized to ensure the best outcomes with regard to tumor control and functional status. As a result, patient management has become controversial, with strong opinions often dictating "optimal" therapy. This review of the management of brain metastases focuses on whole brain radiation therapy, surgery, stereotactic radiosurgery, radiation sensitizers, and clinical trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19348711     DOI: 10.1007/s11910-009-0033-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  55 in total

1.  Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

Authors:  Hidefumi Aoyama; Masao Tago; Norio Kato; Tatsuya Toyoda; Masahiro Kenjyo; Saeko Hirota; Hiroki Shioura; Taisuke Inomata; Etsuo Kunieda; Kazushige Hayakawa; Keiichi Nakagawa; Gen Kobashi; Hiroki Shirato
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-01       Impact factor: 7.038

2.  Long-term survivors after gamma knife radiosurgery for brain metastases.

Authors:  Douglas Kondziolka; Juan J Martin; John C Flickinger; David M Friedland; Adam M Brufsky; Joseph Baar; Sanjiv Agarwala; John M Kirkwood; L Dade Lunsford
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

3.  Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC)

Authors:  A Gregor; A Cull; R J Stephens; J A Kirkpatrick; J R Yarnold; D J Girling; F R Macbeth; R Stout; D Machin
Journal:  Eur J Cancer       Date:  1997-10       Impact factor: 9.162

4.  Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus.

Authors:  W Peissner; M Kocher; H Treuer; F Gillardon
Journal:  Brain Res Mol Brain Res       Date:  1999-07-23

5.  A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

Authors:  K J Murray; C Scott; H M Greenberg; B Emami; M Seider; N L Vora; C Olson; A Whitton; B Movsas; W Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

6.  Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.

Authors:  R Komaki; C A Meyers; D M Shin; A S Garden; K Byrne; J A Nickens; J D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-08-30       Impact factor: 7.038

7.  Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.

Authors:  Christina A Meyers; Jennifer A Smith; Andrea Bezjak; Minesh P Mehta; James Liebmann; Tim Illidge; Ian Kunkler; Jean-Michel Caudrelier; Peter D Eisenberg; Jacobus Meerwaldt; Ross Siemers; Christian Carrie; Laurie E Gaspar; Walter Curran; See-Chun Phan; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2004-01-01       Impact factor: 44.544

8.  Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.

Authors:  Minesh P Mehta; Patrick Rodrigus; C H J Terhaard; Aroor Rao; John Suh; Wilson Roa; Luis Souhami; Andrea Bezjak; Mark Leibenhaut; Ritsuko Komaki; Christopher Schultz; Robert Timmerman; Walter Curran; Jennifer Smith; See-Chun Phan; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

9.  Distribution of brain metastases.

Authors:  J Y Delattre; G Krol; H T Thaler; J B Posner
Journal:  Arch Neurol       Date:  1988-07

10.  RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.

Authors:  Edward Shaw; Charles Scott; John Suh; Sidney Kadish; Baldassarre Stea; John Hackman; Andrew Pearlman; Kevin Murray; Laurie Gaspar; Minesh Mehta; Walter Curran; Michael Gerber
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

View more
  4 in total

Review 1.  Lung cancer: Biology and treatment options.

Authors:  Hassan Lemjabbar-Alaoui; Omer Ui Hassan; Yi-Wei Yang; Petra Buchanan
Journal:  Biochim Biophys Acta       Date:  2015-08-19

2.  Risk factors and treatments for brain metastasis in patients with adenocarcinoma of the lung: a retrospective analysis of 373 patients.

Authors:  Bo Li; Zhaoxia Dai; Shuai Liu; Xuenan Gu; Yanwei Liu; Xiaoguang Qiu
Journal:  Chin Neurosurg J       Date:  2018-04-26

3.  Sarcoma metastatic to the brain: a series of 35 cases and considerations from 27 years of experience.

Authors:  M Salvati; A D'Elia; A Frati; A Santoro
Journal:  J Neurooncol       Date:  2009-12-29       Impact factor: 4.130

4.  Treatment of brain metastasis from lung cancer.

Authors:  Alexander Chi; Ritsuko Komaki
Journal:  Cancers (Basel)       Date:  2010-12-15       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.